Regadenoson
NDC 76329-3321, Regadenoson, injection, solution, from International Medication Systems, Limited.
- Product NDC
- 76329-3321
- Status
- Listed
- Labeler
- International Medication Systems, Limited
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214252
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76329-3321 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REGADENOSON ANHYDROUS.08 mg/mL
Pharmacologic classes
Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76329-3321-0 | 76329332100 | 1 SYRINGE in 1 CARTON (76329-3321-0) / 5 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/288c76cc-ff3e-47ea-ae02-be566bd3e093
Use it
Look up 76329-3321 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76329-3321 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76329-3321. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.